 |
|
|
|
 |
| Heart disease and stroke, the principal components of cardiovascular disease, are the first and third leading causes of mortality in the United States,
accounting for more than 40 percent of all deaths. In addition to the traditional lipid profile, other biomarkers such as homocysteine and lipoprotein (a)
have been gaining recognition as important independent or corroborative indicators of cardiac risk. Inverness Medical Professional Diagnostics offers both the
Homocysteine* and Macra Lp(a)*
ELISA tests as well as the breakthrough ACB® Test to measure levels of Ischemia Modified Albumin, an ischemia marker for
risk stratification of chest pain patients. |
|
| View all cardiac risk assessment tests |
| *Homocysteine and Macra® Lp(a) are manufactured by Axis-Shield and Trinity Biotech, respectively, for Inverness Medical Professional Diagnostics. |
|
|
|
|
| Useful Downloads |
|
|
 |
|
